I have read the same story in about 20 different publications now, all with essentially the same language. It's just not clear whether enrollment has started or finished, or if the trial has started yet from this article or any of the other articles rehashing the initial announcement.
Seems we are unlikely to hear anything substantive until POST-treatment on the 240 patients. In that regard, if the initial information readout on results in treatment recipients versus placebo recipients is strong enough, you'd think they would want to get that out there ASAP.
Cell Therapy News/Articles, page-1832
-
- There are more pages in this discussion • 16,414 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.13 |
Change
0.035(3.21%) |
Mkt cap ! $1.284B | |||
| Open | High | Low | Value | Volume |
| $1.09 | $1.13 | $1.07 | $3.910M | 3.535M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 27197 | $1.11 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.13 | 43578 | 3 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |